Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 14:16:20406223251334439.
doi: 10.1177/20406223251334439. eCollection 2025.

Opportunities and challenges of lifestyle intervention-based digital therapeutics in LDL-C management: a scoping review

Jia Tang  1 , Tiantian Song  1 , Ming Kuang  1   2 , Hongying Liu  3   4   5
Affiliations

Opportunities and challenges of lifestyle intervention-based digital therapeutics in LDL-C management: a scoping review

Jia Tang et al. Ther Adv Chronic Dis. .

Abstract

Background: In recent decades, the prevalence of dyslipidemia, especially high low-density lipoprotein cholesterol (LDL-C), has risen sharply in China. Although lifestyle interventions are important, traditional face-to-face approaches have limitations. Digital Therapeutics (DTx) can provide an effective solution by delivering remote medical interventions to patients via software and hardware, thereby optimizing existing clinical treatment methods with enhanced convenience and accessibility.

Objectives: This study aims to explore the current evidence on the effect of lifestyle intervention-based Digital Therapeutics (LI-DTx) on high LDL-C, and to analyze their advantages and disadvantages.

Eligibility criteria: This scoping review examines clinical studies assessing the effects of DTx on LDL-C levels. Papers were included in the final analysis if there was evidence that DTx had effects on lowering LDL-C levels.

Sources of evidence: Papers that were published between January 2014 and December 2023 were included in the PubMed database.

Charting methods: Data extracted from the publications included country, year, study type, study population, sample size, study duration, intervention, and changes in LDL-C level.

Results: A total of 23 target literature were identified. Twenty-one studies confirmed that LI-DTx could optimize the LDL-C level through remote lifestyle interventions such as diet, exercise, medication, and health education, of which 14 studies reported a significant reduction in LDL-C level (p < 0.05). In the future, the development and design of DTx will need to improve intelligence, personalization, applicability, real-time performance, and data security; integrate with traditional healthcare systems; facilitate multidisciplinary collaboration in dyslipidemia management; and enhance long-term patient engagement with DTx platforms.

Conclusion: LI-DTx may offer a more effective and sustainable solution for LDL-C management, although several challenges remain. Further randomized controlled clinical trials are needed to provide scientific support for its efficacy and safety.

Keywords: LDL-C; applications; cognitive behavior therapy; digital therapeutics; lifestyle modification.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram of literature screening.
Figure 2.
Figure 2.
DTx promote lifestyle changes that affect LDL-C levels.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on Cardiovascular Health and Diseases in China 2021: an updated summary. Biomed Environ Sci 2022; 35(7): 573–603. - PubMed
    1. Na X, Chen Y, Ma X, et al.. Relations of lifestyle behavior clusters to dyslipidemia in China: a compositional data analysis. Int J Environ Res Public Health 2021; 18(15): 7763. - PMC - PubMed
    1. Joint Committee on the Chinese Guidelines for Lipid Management. Chinese guidelines for lipid management (2023). Chin J Cardiol 2023; 51(3): 221–255. - PubMed
    1. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al.. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32(14): 1769–1818. - PubMed
    1. Trautwein EA, McKay S. The role of specific components of a plant-based diet in management of dyslipidemia and the impact on cardiovascular risk. Nutrients 2020; 12(9): 2671. - PMC - PubMed

LinkOut - more resources